AIRLINK 81.20 Increased By ▲ 1.79 (2.25%)
BOP 5.30 Decreased By ▼ -0.03 (-0.56%)
CNERGY 4.48 Increased By ▲ 0.10 (2.28%)
DFML 35.20 Increased By ▲ 2.01 (6.06%)
DGKC 77.95 Increased By ▲ 1.08 (1.4%)
FCCL 20.53 No Change ▼ 0.00 (0%)
FFBL 33.78 Increased By ▲ 2.38 (7.58%)
FFL 9.72 Decreased By ▼ -0.13 (-1.32%)
GGL 10.19 Decreased By ▼ -0.06 (-0.59%)
HBL 117.70 Decreased By ▼ -0.23 (-0.2%)
HUBC 136.18 Increased By ▲ 2.08 (1.55%)
HUMNL 7.00 No Change ▼ 0.00 (0%)
KEL 4.59 Decreased By ▼ -0.08 (-1.71%)
KOSM 4.55 Decreased By ▼ -0.19 (-4.01%)
MLCF 37.50 Increased By ▲ 0.06 (0.16%)
OGDC 137.40 Increased By ▲ 0.70 (0.51%)
PAEL 22.93 Decreased By ▼ -0.22 (-0.95%)
PIAA 26.79 Increased By ▲ 0.24 (0.9%)
PIBTL 6.83 Decreased By ▼ -0.17 (-2.43%)
PPL 114.15 Increased By ▲ 0.40 (0.35%)
PRL 27.68 Increased By ▲ 0.16 (0.58%)
PTC 14.60 Decreased By ▼ -0.15 (-1.02%)
SEARL 57.55 Increased By ▲ 0.35 (0.61%)
SNGP 66.85 Decreased By ▼ -0.65 (-0.96%)
SSGC 10.93 Decreased By ▼ -0.16 (-1.44%)
TELE 9.24 Increased By ▲ 0.01 (0.11%)
TPLP 11.50 Decreased By ▼ -0.06 (-0.52%)
TRG 70.90 Decreased By ▼ -1.20 (-1.66%)
UNITY 25.45 Increased By ▲ 0.63 (2.54%)
WTL 1.34 Decreased By ▼ -0.06 (-4.29%)
BR100 7,629 Increased By 103.2 (1.37%)
BR30 24,766 Increased By 116 (0.47%)
KSE100 72,667 Increased By 695.4 (0.97%)
KSE30 24,029 Increased By 280.3 (1.18%)

KARACHI: Childhood cancer care in Pakistan stands to improve as US-based St. Jude Children’s Research Hospital, a global leader in children’s cancer care and research, launches a series of partnerships aimed at enhancing the standard of oncology services in the country.

St Jude’s Global has built a network of regional partnerships spanning over 50 countries to promote self-sufficiency and the sharing of knowledge, skills and best practices in paediatric cancer under a US$100 million initiative.

A memorandum of understanding in Pakistan has been signed by Doctor Carlos Rodriquez Galindo, executive director at St Jude’s Children’s Research Hospital, and Doctor Adil Haider, dean of AKU’s medical college, at a ceremony on Tuesday.

“The majority of children in the developing world still lose their lives to cancers that can be effectively treated,” said Dr Galindo. “No child should die in the prime of their life and our partnerships with institutions like AKU will play a crucial role in realising our goal of enhancing paediatric cancer survival rates around the world.”

As a member of St. Jude Global’s alliance, AKU’s healthcare professionals and researchers will benefit from a range of capacity building, research and knowledge-sharing initiatives aimed at strengthening Pakistan’s child cancer health system and at developing patient-centered initiatives across the continuum of care.

The partnership will see nurses, paediatric oncology specialists and intensive care unit staff at AKU’s teaching hospital benefit from specialised courses as well as hands-on training at the Memphis-based research hospital. Research faculty will also participate in initiatives to generate new knowledge in the field and to develop collaborative projects with partner institutions in the global network.

Staff at AKU will also work with the Pakistan Society of Paediatric Oncology to extend the benefits of the global partnership to public, private and charity hospitals with paediatric oncology units in the country. Early partners in the alliance with St. Jude Children’s Research Hospital include Indus Hospital and the National Institute of Child Health.

“This partnership is for all children in Pakistan,” said Professor Zehra Fadoo, head of oncology services at AKU’s teaching hospital. “Our specialists see some of the most complicated late-stage cases of childhood cancer cases and we’re keen to collaborate on initiatives that will raise the standard of oncology services across Pakistan.”

An estimated 80 percent of the world’s paediatric cancer patients live in low and middle income countries and the MoU is in line with the University’s commitment to achieve targets under goal three of the Sustainable Development Goals which seek a one-third reduction in cancer mortality and morbidity by 2030.

Copyright Business Recorder, 2019

Comments

Comments are closed.